Current Regulatory Status and Development Trend of Drug Inserts in China
GAO Song, YANG Yue-min, SUN Yuan, SHI Lu-wen*
1.Institute of Chinese Medical Sciences, University of Macau, Macau, China; 2.Baoding No.2 Center Hopsital, Baoding 071051, China; 3.International Research Center for Medicinal Administration, Peking University, Beijing 100083, China
[1] Wang FF, Cheng YL et al. [J]. Evaluation of implementation of standard drug package, labels and inserts [J]. J Pediatr Pharm, 2003, 9 (6) : 46-48. [2] Guo YL, Zheng DS et al. Investigation of inserts and labels for OTC in drug market in Shenyang[J]. J Chin Pharm, 2004, 15 (4) : 252-253. [3] Yang X. Investigation and analysis of drug insert service in pharmacies[J]. Chin Pharm, 2004, 15 (8) : 511. [4] Bernardini C, Ambrogi V, et al. How to improve the readability of the patient package leaflet : a survey on the use of colour, print size and layout [J]. Pharm Res, 2001, 43 (5) : 437-440. [5] Miquel AV, Ortin FF, et al. Assessment of the comprehension of new rephrasing drug package inserts[J]. Med Clin (Barc). 2000, 115 (11) : 410-417. [6] Yamada H, Nishimura S, et al. The development and operation of a package inserts service system for electronic medical records[J]. Yakugaku Zasshi. 2003, 123(3) : 201-209.
>
>